SQZ - SQZ Biotechnologies GAAP EPS of -$0.77 beats by $0.06 revenue of $3.5M misses by $0.76M
- SQZ Biotechnologies press release ( NYSE: SQZ ): Q3 GAAP EPS of -$0.77 beats by $0.06 .
- Revenue of $3.5M (-27.1% Y/Y) misses by $0.76M .
- Company had cash and cash equivalents of $84.2 million and anticipates this will be sufficient to fund operating expenses and capital expenditure requirements into the fourth quarter of 2023
For further details see:
SQZ Biotechnologies GAAP EPS of -$0.77 beats by $0.06, revenue of $3.5M misses by $0.76M